RxDoctor Payments Data

Roberto Feliz, MD

Anesthesiology · Westwood, MANPI 1851376446

Payments from drug & device makers

$6,921in general payments, 2019–2025

Across 217 payments — averaging $31.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Spinal Simplicity, LLC$1K
  • Boston Scientific$1K
  • Painteq LLC$737
  • Hydrocision, Inc.$500
  • Electronic Waveform Lab, Inc.$479
  • plus $2K from 23 others

What the payments were for

  • Consulting fees$5007%
  • Travel & lodging$1,69024%
  • Food & beverage$4,72368%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,921 in reported general payments places this provider in the 95th percentile of 1,585 anesthesiology providers in Massachusetts.

See all anesthesiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$526,140
Medicare patients
199
Services billed
6,839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,056$24,501
OxycontinOxycodone Hcl19$20,547
BotoxOnabotulinumtoxina12$15,480
Oxycodone Hcl982$14,615
Gabapentin392$5,098
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen179$4,642
Lidocaine52$4,268
Methadone Hcl112$2,505
Diclofenac Sodium97$1,984
Ibuprofen163$1,892
Cyclobenzaprine Hcl164$1,627
Hydromorphone Hcl99$1,598
Buprenorphine Hcl28$1,478
Pregabalin71$1,460
Tizanidine Hcl102$1,367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieBotox$77$15,48012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,585 anesthesiology providers in Massachusetts.

Other anesthesiology in Westwood

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →